Concepedia

Publication | Open Access

Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5–17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial

67

Citations

19

References

2022

Year

Abstract

GlaxoSmithKline Biologicals; PATH's Malaria Vaccine Initiative.

References

YearCitations

Page 1